Jennifer A. Maynard, Ph.D.
Affiliations: | 2001 | University of Texas at Austin, Austin, Texas, U.S.A. |
Area:
discovery and development of protein therapeutics and applied immunology by capitalizing on state of the art protein engineering, directed evolution and systems biology technologiesGoogle:
"Jennifer Maynard"Mean distance: 11.06
Parents
Sign in to add mentor| George Georgiou | grad student | 2001 | UT Austin | |
| (Engineering antibody therapeutics: Approaches to neutralizing bacterial toxins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Siles N, Schuler M, Maguire C, et al. (2023) SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics. Medrxiv : the Preprint Server For Health Sciences |
| Maynard JA, Segatori L. (2023) Editorial overview: Tissue, cell, and pathway engineering: Recent innovations in biomedical technologies. Current Opinion in Biotechnology. 83: 102981 |
| Silva RP, Huang Y, Nguyen AW, et al. (2023) Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses. Elife. 12 |
| Qerqez AN, Silva RP, Maynard JA. (2023) Outsmarting Pathogens with Antibody Engineering. Annual Review of Chemical and Biomolecular Engineering |
| Bowen JE, Park YJ, Stewart C, et al. (2022) SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Science Immunology. eadf1421 |
| Liu Y, Nguyen AW, Maynard JA. (2022) Engineering antibodies for conditional activity in the solid tumor microenvironment. Current Opinion in Biotechnology. 78: 102809 |
| Goldsmith JA, DiVenere AM, Maynard JA, et al. (2022) Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin. Cell Reports. 40: 111196 |
| DiVenere AM, Amengor D, Silva RP, et al. (2022) Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis. Mbio. e0152722 |
| Liu Y, Lee AG, Nguyen AW, et al. (2022) An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH using mammalian cell display. The Journal of Biological Chemistry. 101798 |
| Costello SM, Shoemaker SR, Hobbs HT, et al. (2022) The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes. Nature Structural & Molecular Biology |